- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04127253
Evaluation of the Hypoalgesic Effects of Transcranial Direct Current (tDCS) in Healthy Subjects
October 14, 2019 updated by: Roy La Touche Arbizu, Universidad Autonoma de Madrid
Evaluation of the Hypoalgesic Effects of Transcranial Direct Current (tDCS) in Combination With Motion Representation Tools in Healthy Subjects: a Double-blind Randomized Placebo-controlled Trial.
The main objective of this research is to evaluate and quantify hypoalgesic effects caused by imagination and observation with or without the presence of transcranial direct current (tDCS) in healthy participants.
The secondary objective of this research is to evaluate the possible relationships between hypoalgesic effects and different physical and cognitive variables such as the ability to generate motor mental images, mental chronometry and levels of physical activity.
Study Overview
Status
Unknown
Conditions
Study Type
Interventional
Enrollment (Anticipated)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Madrid, Spain, 28023
- CSEU La Salle
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- asymptomatic participants
- men and women aged 18 to 65 years
Exclusion Criteria:
- insomnia
- nausea
- headache
- pregnant woman
- use of painkillers in the last twenty four hours
- presence of metal inside the head
- pacemaker
- wound on the area of electrodes' application
- drugs consumer
- recent application of transcranial direct stimulation
- psychiatric disease who lead the subject to a misunderstand of the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: transcranial direct current plus Brain training tools
20 minutes of transcranial direct current stimulation along with the application of motor imagery and action observation
|
This group will carry out an observation training of actions and motor imagery in combination with the stimulation of the transcranial direct current.
|
Placebo Comparator: Placebo transcranial direct current plus Brain training tools
A placebo intervention of direct transcranial stimulation being active during 15 seconds and then it will be turned off the rest of the time until 20 minutes.
This group will also carry out the training of action observation and motor imagery.
|
This group will carry out an observation training of actions and motor imagery in combination with the placebo stimulation of the transcranial direct current, where it will be acrtivo during 15 seconds and then it will be turned off during the rest of the intervention.
|
Sham Comparator: Brain training tools in isolation
This group will act as a control, they will only carry out the training of action observation and motor imagery.
|
This group will act as a control, they will only carry out the training of action observation and motor imagery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pressure pain threshold
Time Frame: Change in Pressure pain threshold just before the start of the intervention, immediately at the end of the intervention and 15 minutes after the end of the intervention
|
Pressure pain threshold has been defined as the minimal amount of pressure at which a sense of pressure first changes to pain or discomfort
|
Change in Pressure pain threshold just before the start of the intervention, immediately at the end of the intervention and 15 minutes after the end of the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ability to generate motor images
Time Frame: Just before the start of the intervention
|
The ability to generate motor images will be measured through The movement imagery questionnaire-revised (MIQ-R) is an 8-item self-report inventory that was used to assess visual and kinesthetic motor imagery ability.
Four different movements are included in the MIQ-R, which is comprised of 4 visual and 4 kinesthetic items.
For each item, participants read a description of the movement.
They then physically performed the movement and were instructed to reassume the starting position after finishing the movement and before performing the mental task, imagining the movement visually or kinesthetically.
Each participant then rated the ease or difficulty of mentally generating that image on a 7-point scale, in which 7 indicates "very easy to see/feel" and 1 "very difficult to see/feel."
The internal consistencies of the MIQ-R have been consistently adequate.
|
Just before the start of the intervention
|
Mental Chronometry
Time Frame: Just before the start of the intervention
|
Mental chronometry is a reliable measure that has been widely used to record objective measurements of the ability to create mental motor images
|
Just before the start of the intervention
|
The degree of physical activity
Time Frame: Just before the start of the intervention
|
The level of physical activity will be assessed using the International Physical Activity Questionnaire, which allows the participants to be divided into 3 groups according to their level of activity, which can be high, moderate, and low or inactive
|
Just before the start of the intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
January 1, 2020
Primary Completion (Anticipated)
June 1, 2020
Study Completion (Anticipated)
July 1, 2020
Study Registration Dates
First Submitted
October 10, 2019
First Submitted That Met QC Criteria
October 14, 2019
First Posted (Actual)
October 15, 2019
Study Record Updates
Last Update Posted (Actual)
October 15, 2019
Last Update Submitted That Met QC Criteria
October 14, 2019
Last Verified
October 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- uammadrid
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain Modulation
-
Hacettepe UniversityCompletedMusculoskeletal Pain | Chronic Neck Pain | Pain Modulation | Cortical Plasticity | Conditioned Pain Modulation | Temporal SummationTurkey
-
Aalborg UniversityCompletedNeuroplasticity | Brain Modulation | Prolonged PainDenmark
-
Northumbria UniversityThe New Zealand Institute for Plant and Food ResearchCompletedMood Modulation | Modulation of CognitionUnited Kingdom
-
Schweinhardt PetraRecruitingLow Back Pain | Compare Pain Modulation Assessments in Pain-free CohortsSwitzerland
-
Imam Abdulrahman Bin Faisal UniversityNot yet recruitingAutonomic Nervous System Modulation
-
Aalborg UniversityDanish National Research FoundationCompletedAcute Pain | Neuroplasticity | Brain Modulation | Somatosensory FunctionDenmark
-
ASST Fatebenefratelli SaccoCompletedAutonomic Nervous System ModulationItaly
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHealthy Volunteers | Statins | Immune ModulationUnited States
-
Fady M Kaldas, M.D., F.A.C.S.RecruitingAsses Immunosuppression Modulation on Renal Recovery Post LTUnited States
-
University of SalamancaCompletedPain | Analgesia | Pain Modulation | Percutaneous Electrolysis | Endogenous Analgesia SystemSpain
Clinical Trials on Sooma transcranial direct current stimulation device plus Brain training tools
-
Universidad Autonoma de MadridCentro Universitario La SalleCompletedBrain Stimulation | Basic PhysiologySpain
-
University of AlbertaAlberta Health servicesActive, not recruitingDepressive Disorder, Major | Depressive Disorder, Treatment-Resistant | Electric Stimulation Therapy | Transcranial Direct Current StimulationCanada
-
Nova Southeastern UniversityTerminatedHIV | Mild Neurocognitive DisorderUnited States
-
Central Institute of Mental Health, MannheimCompleted
-
Minneapolis Veterans Affairs Medical CenterCenter for Veterans Research and EducationCompletedObesity | Impulsivity | Compulsive OvereatingUnited States
-
Mutual de Seguridad Hospital ClinicoRecruitingCognitive Impairment | Traumatic Brain InjuryChile
-
Beth Israel Deaconess Medical CenterNational Institute of Neurological Disorders and Stroke (NINDS)CompletedStroke | Cerebrovascular Accident | Acute Stroke | Acute Cerebrovascular Accident | Apoplexy | CVAUnited States
-
University Medicine GreifswaldActive, not recruitingMultiple SclerosisGermany
-
University of Sao PauloCompletedMAjor Depressive DisorderBrazil
-
University of AarhusTerminatedStroke | NeurorehabilitationDenmark